Dr. Peter Marks, who formerly led the Food and Drug Administration’s oversight of vaccines, has joined the pharmaceutical firm Eli Lilly, the company told The Epoch Times on Oct. 7.
“Lilly continually evaluates breakthrough science which could benefit patients. Peter’s expertise strengthens our abilities across multiple areas, both in our existing portfolio and in our work in emerging areas,” a spokesperson for the company told The Epoch Times via email.
Marks is the senior vice president of molecule discovery for Lilly, and the head of its infectious disease unit.
Lilly does not currently make any vaccines for the U.S. market.
Marks, who has a medical degree and a graduate degree in cell and molecular biology, was director of the FDA’s Center for Biologics Evaluation and Research, which oversees vaccines, for years before resigning in April. Marks cited disagreements with Health Secretary Robert F. Kennedy Jr.
Marks sped up the first COVID-19 vaccine approval because he wanted to enable vaccine mandates and have more people vaccinated, according to internal documents, prompting two other FDA vaccine officials to resign. Marks has said the officials were not moving fast enough in light of the pandemic situation.
Hellbound and Down 